Univ of Louisville, Norton Children's Research Institute
Welcome,         Profile    Billing    Logout  
 6 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sullivan, Janice E
NCT02134301 / 2013-005415-26: Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections

Recruiting
1
52
US
Oritavancin
Melinta Therapeutics, LLC
Gram Positive Bacterial Infections
12/24
06/25
NCT06359522: PDA Occlusion Using NIRS

Recruiting
N/A
20
US
NIRS monitor
University of Louisville, Norton Healthcare
Organ Perfusion Determined by Using NIRS Post Transcatheter PDA Occlusion or Medical Closure of PDA
03/25
09/25
POPS or POP02, NCT04278404: Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Recruiting
N/A
5000
Canada, US
The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:, Aminocaproic acid, Amiodarone, Bosentan, Budesonide, Cefdinir, Cefepime, Ceftazidime, Clindamycin, Clobazam, Dexamethasone, Dexmedetomidine, Dextroamphetamine/Amphetamine, Fosfomycin, Furosemide, Gabapentin, Guanfacine, Hydrocortisone, Labetalol, Meropenem, Metformin, Milrinone, Nalbuphine, Nicardipine, Nifedipine, Oseltamivir, Oxycodone, Risperidone, Sertraline, Sevelamer Carbonate / Sevelamer Hydrochloride, Spironolactone, Terbutaline, Tranexamic acid, Voriconazole, Zolpidem, Azithromycin, Lopinavir/Ritonavir, Ribavirin, Tocilizumab, Anakinra, Aspirin, Canakinumab, Colchicine, Interferon, Remdesivir, Ruxolitinib, Sarilumab, Abatacept, Infliximab
Duke University, The Emmes Company, LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children, Hypertension, Pain, Hyperphosphatemia, Primary Hyperaldosteronism, Edema, Hypokalemia, Heart Failure, Hemophilia, Menorrhagia, Insomnia, Pneumonia, Skin Infection, Arrythmia, Asthma in Children, Bronchopulmonary Dysplasia, Adrenal Insufficiency, Fibrinolysis; Hemorrhage, Attention Deficit Hyperactivity Disorder, Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Coagulation Disorder, Down Syndrome
09/26
09/27
MigAcu, NCT02681211: Auricular Acupuncture vs SOC in Migraine HA

Recruiting
N/A
80
US
Auricular Acupuncture, Ketorolac 0.5mg/kg, max 30mg, Toradol, Metoclopramide 0.1 mg/kg, max 10mg, Reglan, Diphenhydramine 1mg/kg, max 50mg, Benadryl, Normal saline fluid bolus 20mL/kg, max 1000mL, Normal Saline
University of Louisville
Migraine Headache
11/24
11/24
NCT02418442: Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Recruiting
N/A
20000
Europe, Canada, US, RoW
Duke University, Childhood Arthritis and Rheumatology Research Alliance
Rheumatic Joint Disease
06/28
12/28
Michael, Andrew
NCT02134301 / 2013-005415-26: Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections

Recruiting
1
52
US
Oritavancin
Melinta Therapeutics, LLC
Gram Positive Bacterial Infections
12/24
06/25
Fischer, Laura
NCT02134301 / 2013-005415-26: Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections

Recruiting
1
52
US
Oritavancin
Melinta Therapeutics, LLC
Gram Positive Bacterial Infections
12/24
06/25
TANGOKIDS, NCT02687906 / 2016-000656-99: Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections

Recruiting
1
67
US
Vabomere, Combination meropenem and vaborbactam, carbapenem and beta-lactamase inhibitor
Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC), Department of Health and Human Services
Bacterial Infections
12/24
06/25
PRoART, NCT06185062: Pelvic Cancer Registry for Online Adapted Radiotherapy

Recruiting
N/A
846
Europe
University Medical Center Goettingen
Pelvic Tumor, Thoracic Tumor
09/29
04/30
PROJECTION, NCT04246203: Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer

Recruiting
N/A
200
Europe
Liquid Biopsy
Ludwig-Maximilians - University of Munich, Hoffmann-La Roche
Pancreas Cancer
12/24
12/25
DECIDE, NCT06396312: Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression

Recruiting
N/A
130
Europe
Max-Planck-Institute of Psychiatry
Depressive; Disorder, Major, Single Episode, Major, With Psychotic Symptoms, Depressive; Disorder, Major, Single Episode, Major (Without Psychotic Symptoms), Depressive Disorder, Major, Recurrent, With Psychotic Symptoms, Depressive Disorder, Major, Recurrent, Without Psychotic Symptoms, Depressive Disorder, Treatment-Resistant, Class I or II, Depressive Disorder, Major, Moderate, Depressive Disorder, Major, Severe
04/28
04/29
SCC-BAREDU, NCT05396794: Bariatric Education for Women With Obesity and Endometrial Cancer

Recruiting
N/A
80
US
Standard weight loss education, Standard weight loss education + Educational Video
University of Oklahoma
Obesity, Endometrial Cancer, Bariatric Surgery Candidate
08/25
08/26

Download Options